Bench-to-bedside review: Natural killer cells in sepsis - guilty or not guilty?

Critical Care

Volumn 17, Issue 4, 2013, Pages

  Souza Fonseca Guimaraes, Fernando ^a,b   Cavaillon, Jean Marc ^a   Adib Conquy, Minou ^a  

^a INSTITUT PASTEUR   (France)

^b QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CD69 ANTIGEN; COMPLEMENT COMPONENT C5A; ENDOTOXIN; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 18; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR; NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN LIKE RECEPTOR; PATTERN RECOGNITION RECEPTOR; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 9; TRANSFORMING GROWTH FACTOR BETA1; AUTACOID;

CYTOKINE STORM; CYTOTOXICITY; DENDRITIC CELL; ENVIRONMENTAL FACTOR; FEMUR FRACTURE; HEMORRHAGIC SHOCK; HOSPITAL INFECTION; HUMAN; IMMUNOSURVEILLANCE; INNATE IMMUNITY; LEUKOCYTE; LYMPHOCYTE; MAJOR HISTOCOMPATIBILITY COMPLEX; MICROENVIRONMENT; NATURAL KILLER CELL; NEUTROPHIL CHEMOTAXIS; NONHUMAN; POLYMORPHONUCLEAR CELL; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; REVIEW; SEPSIS; SEPTIC SHOCK; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TISSUE INJURY; ANIMAL; IMMUNOLOGY;

ANIMALS; HUMANS; INFLAMMATION MEDIATORS; KILLER CELLS, NATURAL; SEPSIS;

EID: 84884984958     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc12700     Document Type: Review

References (60)

1. Herzum I, Renz H. Inflammatory markers in SIRS, sepsis and septic shock. Curr Med Chem 2008, 15:581-587. 10.2174/092986708783769704, 18336272.
2. Adib-Conquy M, Cavaillon JM. Stress molecules in sepsis and systemic inflammatory response syndrome. FEBS Lett 2007, 581:3723-3733. 10.1016/j.febslet.2007.03.074, 17428476.
3. Cavaillon JM, Adib-Conquy M. Bench-to-bedside review: endotoxin tolerance as a model of leukocyte reprogramming in sepsis. Crit Care 2006, 10:233. 10.1186/cc5055, 1751079, 17044947.
4. Miller JFA, Brunner KT, Sprent J, Russell PJ, Mitchell GF. Thymus-derived cells as killer cells in cell-mediated immunity. Transplant Proc 1971, 3:915-917.
5. Kiessling R, Klein E, Pross H, Wigzell H. "Natural" killer cells in the mouse. II. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Characteristics of the killer cell. Eur J Immunol 1975, 5:117-121. 10.1002/eji.1830050209, 1086218.
6. Macfarlan RI, Burns WH, White DO. Two cytotoxic cells in peritoneal cavity of virus-infected mice: antibody-dependent macrophages and nonspecific killer cells. J Immunol 1977, 119:1569-1574.
7. Moretta A, Bottino C, Vitale M, Pende D, Biassoni R, Mingari MC, Moretta L. Receptors for HLA class-I molecules in human natural killer cells. Annu Rev Immunol 1996, 14:619-648. 10.1146/annurev.immunol.14.1.619, 8717527.
8. Huntington ND, Vosshenrich CAJ, Di Santo JP. D evelopmental pathways that generate natural-killer-cell diversity in mice and humans. Nat Rev Immunol 2007, 7:703-714. 10.1038/nri2154, 17717540.
9. Newman KC, Riley EM. Whatever turns you on: accessory-cell-dependent activation of NK cells by pathogens. Nat Rev Immunol 2007, 7:279-291. 10.1038/nri2057, 17380157.
10. Souza-Fonseca-Guimaraes F, Adib-Conquy M, Cavaillon JM. Natural Killer (NK) cells in antibacterial innate immunity: angels or devils?. Mol Med 2012, 18:270-285. 3324953, 22105606.
11. Doherty GM, Lange JR, Langstein HN, Alexander HR, Buresh CM, Norton JA. Evidence for IFN-gamma as a mediator of the lethality of endotoxin and tumor necrosis factor-alpha. J Immunol 1992, 149:1666-1670.
12. Bohannon J, Guo Y, Sherwood ER. The role of natural killer cells in the pathogenesis of sepsis: the ongoing enigma. Crit Care 2012, 16:185. 10.1186/cc11881, 3672611, 23234545.
13. Souza-Fonseca-Guimaraes F, Parlato M, Fitting C, Cavaillon JM, Adib-Conquy M. NK cell tolerance to TLR agonists mediated by regulatory T cells after polymicrobial sepsis. J Immunol 2012, 188:5850-5858. 10.4049/jimmunol.1103616, 22566566.
14. Souza-Fonseca-Guimaraes F, Parlato M, Philippart F, Misset B, Cavaillon JM, Adib-Conquy M, Study Group C. Toll-like receptors expression and interferon-gamma production by NK cells in human sepsis. Crit Care 2012, 16:R206. 10.1186/cc11838, 3682310, 23098236.
15. Souza-Fonseca-Guimaraes F, Parlato M, de Oliveira RB, Golenbock D, Fitzgerald K, Shalova IN, Biswas SK, Cavaillon JM, Adib-Conquy M. Interferon-gamma and granulocyte/monocyte colony-stimulating factor production by natural killer cells involves different signaling pathways and the adaptor stimulator of interferon genes (STING). J Biol Chem 2013, 288:10715-10721. 10.1074/jbc.M112.435602, 23443666.
16. Goguel AF, Payelle B, Quan PC, Lespinats G. Stimulation of one particular subset of natural killer cells by peptidoglycans extracted from gram-positive bacteria. J Natl Cancer Inst 1984, 73:697-703.
17. Cuturi MC, Murphy M, Costa-Giomi MP, Weinmann R, Perussia B, Trinchieri G. Independent regulation of tumor necrosis factor and lymphotoxin production by human peripheral blood lymphocytes. J Exp Med 1987, 165:1581-1594. 10.1084/jem.165.6.1581, 2188372, 3108447.
18. Kim S, Iizuka K, Aguila HL, Weissman IL, Yokoyama WM. In vivo natural killer cell activities revealed by natural killer cell-deficient mice. Proc Natl Acad Sci USA 2000, 97:2731-2736. 10.1073/pnas.050588297, 15998, 10694580.
19. Varma TK, Lin CY, Toliver-Kinsky TE, Sherwood ER. Endotoxin-induced gamma interferon production: contributing cell types and key regulatory factors. Clin Diagn Lab Immunol 2002, 9:530-543. 119981, 11986256.
20. Agerberth B, Charo J, Werr J, Olsson B, Idali F, Lindbom L, Kiessling R, Jornvall H, Wigzell H, Gudmundsson GH. The human antimicrobial and chemotactic peptides LL-37 and alpha-defensins are expressed by specific lymphocyte and monocyte populations. Blood 2000, 96:3086-3093.
21. Etogo AO, Nunez J, Lin CY, Toliver-Kinsky TE, Sherwood ER. NK but not CD1-restricted NKT cells facilitate systemic inflammation during polymicrobial intra-abdominal sepsis. J Immunol 2008, 180:6334-6345. 3413484, 18424757.
22. Badgwell B, Parihar R, Magro C, Dierksheide J, Russo T, Carson WE. Natural killer cells contribute to the lethality of a murine model of Escherichia coli infection. Surgery 2002, 132:205-212. 10.1067/msy.2002.125311, 12219013.
23. Goldmann O, Chhatwal GS, Medina E. Contribution of natural killer cells to the pathogenesis of septic shock induced by Streptococcus pyogenes in mice. J Infect Dis 2005, 191:1280-1286. 10.1086/428501, 15776374.
24. Stevenson HL, Estes MD, Thirumalapura NR, Walker DH, Ismail N. Natural killer cells promote tissue injury and systemic inflammatory responses during fatal Ehrlichia-induced toxic shock-like syndrome. Am J Pathol 2010, 177:766-776. 10.2353/ajpath.2010.091110, 2913354, 20616341.
25. Carson WE, Yu H, Dierksheide J, Pfeffer K, Bouchard P, Clark R, Durbin J, Baldwin AS, Peschon J, Johnson PR, Ku G, Baumann H, Caligiuri MA. A fatal cytokine-induced systemic inflammatory response reveals a critical role for NK cells. J Immunol 1999, 162:4943-4951.
26. Bozinovski S, Jones JE, Vlahos R, Hamilton JA, Anderson GP. Granulocyte/macrophage-colony-stimulating factor (GM-CSF) regulates lung innate immunity to lipopolysaccharide through akt/Erk activation of nfkb and AP-1 in vivo. J Biol Chem 2002, 277:42808-42814. 10.1074/jbc.M207840200, 12208854.
27. Wollin L, Uhlig S, Nusing R, Wendel A. Granulocyte-macrophage colony-stimulating factor amplifies lipopolisaccharide-induced bronchoconstriction by a neutrophil- and cyclooxigenase 2-dependent mechanism. Am J Respir Crit Care Med 2001, 163:443-450. 10.1164/ajrccm.163.2.2004031, 11179120.
28. Verhoef G, Boogaerts M. Treatment with granulocyte-macrophage colony stimulating factor and the adult respiratory distress syndrome. Am J Hematol 1991, 36:285-287. 10.1002/ajh.2830360413, 1672790.
29. Anthony DA, Andrews D, Chow M, Watt SV, House C, Akira S, Bird PI, Trapani JA, Smyth MJ. A role of granzyme M in TLR4-driven inflammation and endotoxicosis. J Immunol 2010, 185:1794-1803. 10.4049/jimmunol.1000430, 20585036.
30. Barkhausen T, Frerker C, Putz C, Pape HC, Krettek C, van Griensven M. Depletion of NK cells in a murine polytrauma model is associated with improved outcome and a modulation of the inflammatory response. Shock 2008, 30:401-410. 10.1097/SHK.0b013e31816e2cda, 18391857.
31. Fusakio ME, Mohamed JP, Laumonnier Y, Hoebe K, Kohl J, Mattner J. C5a regulates NKT and NK cell function in sepsis. J Immunol 2011, 187:5805-5812. 10.4049/jimmunol.1100338, 3242514, 22058413.
32. Cavaillon JM, Adib-Conquy M, Cloez-Tayarani I, Fitting C. Immunodepression in sepsis and SIRS assessed by ex vivo cytokine production is not a generalized phenomenon: a review. J Endotox Res 2001, 7:85-93.
33. Adib-Conquy M, Cavaillon JM. Compensatory anti-inflammatory response syndrome. Thrombosis Haemostasis 2009, 101:36-47.
34. Cavaillon JM, Adrie C, Fitting C, Adib-Conquy M. Reprogramming of circulatory cells in sepsis and SIRS. J Endotox Res 2005, 11:311-320.
35. Deknuydt F, Roquilly A, Cinotti R, Altare F, Asehnoune K. An in vitro model of Mycobacterial granuloma to investigate the immune response in brain-injuried patients. Crit Care Med 2013, 41:245-254.
36. Venet F, Pachot A, Debard AL, Bohe J, Bienvenu J, Lepape A, Monneret G. Increased percentage of CD4+CD25+regulatory T cells during septic shock is due to the decrease of CD4+CD25-lymphocytes. Crit Care Med 2004, 32:2329-2331.
37. Venet F, Chung CS, Kherouf H, Geeraert A, Malcus C, Poitevin F, Bohe J, Lepape A, Ayala A, Monneret G. Increased circulating regulatory T cells (CD4(+) CD25(+)CD127(-)) contribute to lymphocyte anergy in septic shock patients. Intensive Care Med 2009, 35:678-686. 10.1007/s00134-008-1337-8, 2789433, 18946659.
38. Monneret G, Debard AL, Venet F, Bohe J, Hequet O, Bienvenu J, Lepape A. Marked elevation of human circulating CD4+CD25+ regulatory T cells in sepsis-induced immunoparalysis. Crit Care Med 2003, 31:2068-2071. 10.1097/01.CCM.0000069345.78884.0F, 12847405.
39. Kessel A, Bamberger E, Masalha M, Toubi E. The role of T regulatory cells in human sepsis. J Autoimmun 2009, 32:211-215. 10.1016/j.jaut.2009.02.014, 19345068.
40. Campbell DJ, Koch MA. Phenotypical and functional specialization of FOXP3(+) regulatory T cells. Nat Rev Immunol 2011, 11:119-130. 10.1038/nri2916, 3289970, 21267013.
41. Venet F, Pachot A, Debard AL, Bohe J, Bienvenu J, Lepape A, Powell WS, Monneret G. Human CD4(+)CD25(+) regulatory T lymphocytes inhibit lipopolysaccharide-induced monocyte survival through a Fas/Fas ligand-dependent mechanism. J Immunol 2006, 177:6540-6547.
42. Cavassani KA, Carson WF 4, Moreira AP, Wen H, Schaller MA, Ishii M, Lindell DM, Dou Y, Lukacs NW, Keshamouni VG, Hogaboam CM, Kunkel SL. The post sepsis-induced expansion and enhanced function of regulatory T cells create an environment to potentiate tumor growth. Blood 2010, 115:4403-4411. 10.1182/blood-2009-09-241083, 2881495, 20130237.
43. Kanevskiy LM, Telford W, Sapozhnikov AM, Kovalenko EI. Lipopolisaccharide induces IFN-gamma production in human NK cells. Front Immunol 2013, 4:R243. 3556587, 23372571.
44. Holub M, Kluckova Z, Helcl M, Prihodov J, Rokyta R, Beran O. Lymphocyte subset numbers depend on the bacterial origin of sepsis. Clin Microbiol Infect 2003, 9:202-211. 10.1046/j.1469-0691.2003.00518.x, 12667252.
45. Gregoire C, Chasson L, Luci C, Tomasello E, Geissmann F, Vivier E, Walzer T. The trafficking of natural killer cells. Immunol Rev 2007, 220:169-182. 10.1111/j.1600-065X.2007.00563.x, 17979846.
46. Herzig DS, Driver BR, Fang GP, Toliver-Kinsky TE, Shute EN, Sherwood ER. Regulation of lymphocyte trafficking by CXC chemokine receptor 3 during septic shock. Am J Respir Crit Care Med 2012, 185:291-300. 10.1164/rccm.201108-1560OC, 3297107, 22135342.
47. Hotchkiss RS, Nicholson DW. Apoptosis and caspases regulate death and inflammation in sepsis. Nat Rev Immunol 2006, 6:813-822. 10.1038/nri1943, 17039247.
48. Giamarellos-Bourboulis EJ, Tsaganos T, Spyridaki E, Mouktaroudi M, Plachouras D, Vaki I, Karagianni V, Antonopoulou A, Veloni V, Giamarellou H. Early changes of CD4-positive lymphocytes and NK cells in patients with severe Gram-negative sepsis. Crit Care 2006, 10:R166. 10.1186/cc5111, 1794479, 17129388.
49. Andaluz-Ojeda D, Iglesias V, Bobillo F, Almansa R, Rico L, Gandía F, Loma AM, Nieto C, Diego R, Ramos E, Nocito M, Resino S, Eiros JM, Tamayo E, de Lejarazu RO, Bermejo-Martin JF. Early natural killer cell counts in blood predict mortality in severe sepsis. Crit Care 2011, 15:R243. 10.1186/cc10501, 3334794, 22018048.
50. de Pablo R, Monserrat J, Reyes E, Diaz D, Rodriguez-Zapata M, de la Hera A, Prieto A, Alvarez-Mon M. Sepsis-induced acute respiratory distress syndrome with fatal outcome is associated to increased serum transforming growth factor beta-1 levels. Eur J Intern Med 2012, 23:358-362. 10.1016/j.ejim.2011.10.001, 22560386.
51. Maturana P, Puente J, Miranda D, Sepulveda C, Wolf ME, Mosnaim AD. Natural-killer-cel activity in patients with septic shock. J Crit Care 1991, 6:42-45.
52. Georgeson GD, Szony BJ, Streitman K, Kovacs A, Kovacs L, Laszlo A. Natural killer cell cytotoxicity is deficient in newborns with sepsis and recurrent infections. Eur J Pediatr 2001, 160:478-482. 10.1007/s004310100773, 11548185.
53. Blazar BA, Rodrick ML, Omahony JB, Wood JJ, Bessey PQ, Wilmore DW, Mannick JA. Suppression of natural-killer-cell function in humans following thermal and traumatic injury. J Clin Immunol 1986, 6:26-36. 10.1007/BF00915361, 3485653.
54. Klimpel GR, Herndon DN, Fons M, Albrecht T, Asuncion MT, Chin R, MD S. Defective NK cell-activity following thermal-injury. Clin Exp Immunol 1986, 66:384-392. 1542543, 3493101.
55. Chiche L, Forel JM, Thomas G, Farnarier C, Vely F, Bléry M, Papazian L, Vivier E. The role of natural killer cells in sepsis. J Biomed Biotechnol 2011, 2011:986491. 3100670, 21629707.
56. Hiraki S, Ono S, Kinoshita M, Tsujimoto H, Seki S, Mochizuki H. Interleukin-18 restores immune suppression in patients with nonseptic surgery, but not with sepsis. Am J Surg 2007, 193:676-680. 10.1016/j.amjsurg.2006.10.021, 17512275.
57. Giannikopoulos G, Kalpakou G, Makaritsis K, Panou C, Papadomichelakis E, Sinapidis D, Theodotou A, Tzagkaraki A, Giamarellos-Bourboulis EJ. The functional role of natural killer cells early in clinical sepsis. APMIS 2013, 121:329-336. 10.1111/apm.12002, 23072664.
58. Forel JM Chiche L, Thomas G, Mancini J, Farnarier C, Cognet C, Guervilly C, Daumas A, Vély F, Xéridat F, Vivier E, Papazian L. Phenotype and functions of natural killer cells in critically-ill septic patients. PLoS One 2012, 7:e50446. 10.1371/journal.pone.0050446, 3516510, 23236375.
59. Chiche L, Forel JM, Thomas G, Farnarier C, Cognet C, Guervilly C, Zandotti C, Vély F, Roch A, Vivier E, Papazian L. Interferon-γ production by natural killer cells and cytomegalovirus in critically ill patients. Crit Care Med 2012, 40:3162-3169. 10.1097/CCM.0b013e318260c90e, 22971588.
60. Cavaillon JM. "Septic plasma", an immunosuppressive milieu. Am J Respir Crit Care Med 2002, 166:1417-1422. 10.1164/rccm.2209003, 12450929.